Tirzepatide or semaglutide?
One produced larger average weight loss in a head-to-head trial. The other is gentler on the wallet and, for some people, on the stomach.
Updated 2026-09-18
How we are paid: one company on this page — Coreage Rx — pays us a commission if you sign up through our link. It does not buy a better score, a higher position, or the removal of a single criticism. Our rating method and full disclosure are both public.
Both are weekly injections. Both reduce appetite. They are not the same drug, and there is a trial that compared them directly.
SURMOUNT-5 compared the two drugs directly. Participants on tirzepatide lost an average of 50.3 lb (22.8 kg); those on semaglutide lost 33.1 lb (15.0 kg). That is a substantial difference, and it is the main reason tirzepatide costs more nearly everywhere you look.
How they differ
Tirzepatide — A single weekly injection that activates two gut hormone receptors, GIP and GLP-1, rather than one. Sold as Zepbound and Mounjaro. In SURMOUNT-1, adults with obesity lost an average of 19.5% of body weight on 10 mg and 20.9% on 15 mg over 72 weeks.
Semaglutide — A weekly injection that activates the GLP-1 receptor, slowing stomach emptying and reducing appetite signalling. Sold as Wegovy and Ozempic. In STEP-1, adults on 2.4 mg lost an average of about 14.9% of body weight over 68 weeks.
Reasons people choose semaglutide anyway
- It costs less almost everywhere — roughly $149 to $298 a month against $199 to $449 for tirzepatide.
- It has been in wide use longer, so there is more accumulated real-world experience.
- Some people tolerate it better, though both carry the same broad side-effect profile.
- Insurance is somewhat more likely to have a pathway for branded semaglutide.
The dose ladders side by side
| Tirzepatide | Semaglutide | |
|---|---|---|
| Doses | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg | 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg |
| Step up every | ~4 weeks | ~4 weeks |
| Cheapest all-in | $199/mo | $149/mo |
| Typical all-in | $278–$449/mo | $178–$297/mo |
Full tables in the cheapest weekly shots.
Side effects
Tirzepatide: Nausea, diarrhoea, constipation and reflux, concentrated in the weeks after each dose increase.
Semaglutide: Nausea, vomiting, diarrhoea and constipation, usually worst in the first weeks and after dose increases.
For both, the pattern follows the dose increases — see side effects week by week.
So which?
If budget is the constraint, semaglutide is the sensible starting point and still produced about 15% average weight loss in its trials. If you can afford the difference and want the larger average result, tirzepatide. Either way it is a decision for the clinician who will be prescribing — both have contraindications, and neither is right for everyone.
Read next
- The dose ladder
Why you start low, how fast you climb, and why the price of each rung matters more than people expect.
- The cheapest weekly shots
Every programme sorted on what leaves your account each month, with membership fees counted and teaser rates ignored.
- Side effects, week by week
What most people get, when it usually settles, and the signs that mean stop and call someone.
- Is compounded medication still legal?
Yes, but much more narrowly than in 2024. What changed, and the five questions to ask before you start.
- Best programmes if this is your first time
Ranked on how they price the dose ladder and how reachable support is — the two things that decide whether a beginner stays on treatment.